A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer-Reference-Cited by-同舟云学术

A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer

Published:2024-03 Issue:1 Volume:9 Page:185-193
ISSN:2468-0540
Container-title:Non-coding RNA Research
language:en
Short-container-title:Non-coding RNA Research

Author:

Gupta Shantanu^ORCID,Silveira Daner A.,Piedade Gabriel P.S.,Ostrowski Miguel P.,Mombach José Carlos M.^ORCID,Hashimoto Ronaldo F.^ORCID

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

FAPESP

Publisher

Elsevier BV

Subject

Biochemistry (medical),Genetics,Molecular Biology,Biochemistry

Reference57 articles.

1. Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer;Cui;Oncol. Lett.,2018

2. miR-145-5p targets Sp1 in non-small cell lung cancer cells and links to BMI1 induced pemetrexed resistance and epithelial–mesenchymal transition;Chang;Int. J. Mol. Sci.,2022

3. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor;Li;J. Cancer Res. Clin. Oncol.,2015

4. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc;Chen;J. Exp. Clin. Cancer Res.,2010

5. miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade;Pan;Oncol. Lett.,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin;Biomarker Research;2024-02-05